H. Gadner

Compassionate use of bevacizumab (Avastin(R)) in children and young adults with refractory or recurrent solid tumors (2008)

Benesch, M., Windelberg, M., Sauseng, W., Witt, V., Fleischhack, G., Lackner, H., ...

Background: The aim of this study was to evaluate feasibility and toxicity of bevacizumab (Avastin®), a monoclonal antibody directed against the vascular endothelial growth factor in children and...

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial (2007)

CONTER, V, VALSECCHI, MG, SILVESTRI, D, CAMPBELL, M, DIBAR, E, MAGYAROSY, E, ...

The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di Legno meeting') report: Vienna, Austria, April 27-28, 2005 (2006)

GADNER, H, MASERA, G, SCHRAPPE, M, EDEN, T, Benoit, Yves, HARRISON, C, ...

Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia (2005)

Tognoni, G., Masera, G., Eden, T., Nachman, J., Gadner, H., ...

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements (2003)

Pui, C.H., Chessells, J.M., Camitta, B., Baruchel, A., Biondi, A., Boyett, J.M., ...

To assess the clinical heterogeneity among patients with acute lymphoblastic leukemia (ALL) and various 11q23 abnormalities, we analyzed data on 497 infants, children and young adults treated between...

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL (2002)

Willemse, M.J., Hop, W.C., Panzer-Grumayer, E.R., Biondi, A., Dongen, J.J. Van, Schrappe, M., ...

We performed sensitive polymerase chain reaction-based minimal residual disease (MRD) analyses on bone marrow samples at 9 follow-up time points in 71 children with T-lineage acute lymphoblastic...

Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86 (2001)

Paulussen, M., Ahrens, S., Dunst, J., Winkelmann, W., Exner, G.U., Kotz, R., ...

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European intergroup cooperative Ewing's sarcoma study group (2000)

Cotterill, S.J., Ahrens, S., Paulussen, M., Jurgens, H.F., Voute, P.A., Gadner, H., ...

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors: An update after long-term follow-up from two centers of the European Intergroup Study EICESS (2000)

Burdach, S., Van Kaick, B., Laws, H. J., Ahrens, S., Haase, R., Körholz, D., ...

Background An update of results from the High Risk Protocol of the Meta-EICESS Study, conducted at the Pediatric Stem-Cell Transplant Centers of Düsseldorf and Vienna. In order to evaluate a...

Intensive traetment of children with acute leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch childhood leukemia study group protocol ALL-7 (1988-1991) (1999)

Kamps, W.A., Bokkerink, J.P.M/, Hahlen, K., Hermans, J., Riehm, H., Gadner, H., ...

European intergroup cooperative Ewing's sarcoma study (EICESS 92) (1998)

Jurgens, A., Craft, W., Gadner, H., Voûte, P.A., Souhani, R.

Abstract (1992)

Strohscheer, I., Kleinert, R., Westphal, C., Schüller, J., Werner, K., Anders, O., ...

Peer Reviewed

T cell differentiation and generation of the antigen-specific T cell repertoire in man: observations in MHC class II deficiency.

Mannhalter, J W, Wolf, H M, Hauber, I, Miricka, M, Gadner, H, Eibl, M M

The circulating T cell pool of an MHC class II-deficient patient was shown to lack the MHC class II-specific T cell functions. This was demonstrated by the absence of MHC class II-specific...

Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.

Aryee, D. N., Simonitsch, I., Mosberger, I., Kos, K., Mann, G., Schlögl, E., ...

The nm23-H1 gene is a putative metastasis-suppressor gene encoding a 17 kDa protein with nucleoside diphosphate kinase activity. Expression of nm23-H1/NDPK-A correlates inversely with the...

Prognostic impact of chromosomal aberrations in Ewing tumours

Hattinger, C M, Pötschger, U, Tarkkanen, M, Squire, J, Zielenska, M, Kiuru-Kuhlefelt, S, ...

Although greater than 50% of Ewing tumours contain non-random cytogenetic aberrations in addition to the pathognomonic 22q12 rearrangements, little is known about their prognostic significance. To...

Treatment of Langerhans cell histiocytosis--evolution and current approaches.

Ladisch, S., Gadner, H.

Optimal treatment of Langerhans cell histiocytosis remains problematic. The absence of controlled studies and the lack of standard diagnostic and evaluation criteria have impeded therapeutic progress...